Duloxetin-Mepha 30 mg, magensaftresistente Hartkapseln

7680660980077 CH-66098 Magensaftresistente Hartkapseln

Associated product:

DULOXETIN Mepha caps 30 mg bte 100 pce
Duloxetin-Mepha 30 mg, magensaftresistente Hartkapseln
Duloxetin-Mepha 30 mg, magensaftresistente Hartkapseln
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
100
Selling units
100
Measure
Kapsel(n)
Galenic form
Magensaftresistente Hartkapseln
Galenic group
Gastrointenstinales Therapiesystem

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/04/2025
Patient information leaflet
Français
26/04/2025
Patient information leaflet
Italien
26/04/2025
Summary of Product Characteristics
Allemand
26/04/2025
Summary of Product Characteristics
Français
26/04/2025
Summary of Product Characteristics
Italien
26/04/2025

Detailed composition

Substance Quantity Type Category
duloxetinum
30.0 MG Substance Wirkstoff (Principe actif)
duloxetini hydrochloridum
- Substance WIZUS
sacchari sphaerae
- Substance HNIDK
saccharum
- Substance HBESI
hydroxypropylcellulosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
hypromellosi phthalas
- Substance HNIDK
triethylis citras
- Substance HNIDK
talcum
- Substance HNIDK
hypromellosum
- Substance HNIDK
E 133
- Substance FIMDK
E 171
- Substance FNIDK
E 172 (nigrum)
- Substance FTODK
lacca
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
ammoniae solutio concentrata
- Substance HNIDK
E 172 (nigrum)
- Substance FTODK
kalii hydroxidum
- Substance HNIDK

Reimbursement information

Public price
CHF 50.80
Specialties list
Yes
Generic
Yes
SL addition date: 01/07/2019

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66098
Drug name
Duloxetin-Mepha, magensaftresistente Hartkapseln
Galenic form
KAHAM
ATC Code
N06AX21
Authorization status
Z
Dispensing category
B
First authorization
02/03/2017
Authorization expiration date
31/12/9999
IT Number
01.06.0.
Domain
Human medicine
Field of application
Antidepressivum, Schmerzen bei diabetischer Neuropathie, generalisierte Angststörung

Package details

Description (FR)
DULOXETIN Mepha caps 30 mg bte 100 pce
Description (DE)
DULOXETIN Mepha Kaps 30 mg Ds 100 Stk
Market launch
02/03/2017
Narcotic (BTM)
No

Other package sizes (10)

None
None None
GTIN: None
Not in V1
DULOXETIN Mepha caps 30 mg 30 pce
30 KAP
GTIN: 7680660980053
View
DULOXETIN Mepha caps 30 mg 100 pce
100 KAP
GTIN: 7680660980060
View
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
DULOXETIN Mepha caps 60 mg 10 pce
10 KAP
GTIN: 7680660980084
View
DULOXETIN Mepha caps 60 mg 30 pce
30 KAP
GTIN: 7680660980091
View
DULOXETIN Mepha caps 60 mg 100 pce
100 KAP
GTIN: 7680660980107
View
DULOXETIN Mepha caps 60 mg bte 90 pce
90 KAP
GTIN: 7680660980114
View
Buy us a coffee Explore the data